Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

APPLICATIONS ARE NOW OPEN – DEADLINE 2 MAY The Unlocking Ambition Challenge will invest in a group of up to 20 early stage entrepreneurs who will be chosen, mentored and led by some of Scotland’s leading entrepreneurs. They’re looking for early-stage, high-potential entrepreneurs, innovators, academics and...

A two-year-long discovery chemistry collaboration between Charnwood Molecular and Forendo Pharma has seen compounds move from discovery to pre-clinical development.Charnwood Molecular and Forendo Pharma have been collaborating since September 2015, with Charnwood Molecular synthesising challenging steroidal analogues of a hit compound initially identified at Forendo...

Aseptika and BioHub based, Zenzium, Ltd., have been awarded a grant from the UK’s innovation agency to develop a new home-based early warning system for people with severe respiratory disease. Artificial Intelligence (AI) will automatically analyse and learn from data generated by the patient at...

NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne.  Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...